Preparation and in-vitro assessment of Tolbutamide nanosponges – Indian Journal of Research Methods in Pharmaceutical Sciences

Preparation and in-vitro assessment of Tolbutamide nanosponges

Publication Date : 02-03-2022


Author(s) :

Sushama Vaishnav, Gajanan Vaishnav, Abhay Joshi, Yuvraj Girbane.


Volume/Issue :
Volume 1
,
Issue 2
(03 - 2022)



Abstract :

In this research, we have used polyethylene to characterise and produce Nanosponges tolbutamide oral formulations (poly-caprolactone). For decades, efficient targeted pharmaceutical distribution technologies have been a pipe dream. Nanosponges drug delivery technology has emerged as one of the most promising new medication delivery methods. Nanosponges drug delivery technology has recently become a significant advancement in overcoming various biopharmaceutical challenges. Before it reaches the precise target surface, the Nanosponges target the medicine in the body's systemic circulation and begin to release the drug in a controlled and consistent way. A broad range of drug molecules have been filled with hydrophilic and lipophilic drug material in Nanosponges medicine release devices. As a result, the Nanosponges are a suitable target carrier molecule. The medicine may be given at a specific place in the Nanosponges approach, preventing the drug from destroying proteins and extending drug release in a predictable manner. According to the FTIR and DSC investigations, there was no significant association between the medication and the excipients. In nanoscale ranges, prepared nanoparticles having spherical shape have been found to be resilient. The rubber's surface, which has an explosive effect and indicates that action is about to begin, exposes free material particles. Drug release studies indicate that drugs will continue to be released into the polymeric matrix. The tolbutamide-loaded nano-carrying unit was absorbed with continuous drug release patterns in this study, demonstrating the effectiveness of increased solubility.


No. of Downloads :

22